Diana Meske

Chief Clinical Development Officer

BSc, PhD

Diana brings more than 15 years of pharmaceutical and clinical development experience to Relevium Medical, with a career focused on analgesic drug development, clinical data analysis, and biostatistics. She previously served as Director of Clinical Development at Centrexion Therapeutics and Senior Director of Clinical Development at Concentric Analgesics, where she contributed to the advancement of TRPV1-targeted pain therapies, including capsaicin-based compounds. Her broad expertise spans clinical development, regulatory affairs, nonclinical research, biostatistics, and business development.

Diana holds a PhD in Medical Pharmacology from the University of Arizona, where her research focused on analgesic efficacy and neuropharmacology.

Outside of her professional work, Dr Meske is passionate about animal welfare and devotes much of her spare time to rescuing street dogs and nursing them back to health.